|
FY2023
12 months to Sep 30, 2023
|
FY2021
12 months to Sep 30, 2021
|
FY2020
12 months to Sep 30, 2020
|
FY2019
12 months to Sep 30, 2019
|
FY2018
12 months to Sep 30, 2018
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of goods sold | |||||
| Gross Profit | |||||
| Operating expenses: | |||||
| Consulting fees | |||||
| Professional fees | |||||
| General and administrative | |||||
| Stock based compensation | |||||
| Impairment of intangible assets | |||||
| Impairment expense | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expenses), net | |||||
| Interest expense | |||||
| Change in fair value of derivative liability | |||||
| Change in fair value of warrant liability | |||||
| Foreign currency exchange gain (loss) | |||||
| Other income | |||||
| Total other income (expense) | |||||
| Loss from equity method investees | |||||
| Loss from continuing operations | |||||
| Loss from discontinued operations, net of tax | |||||
| Net income (loss) | |||||
| Net loss attributable to non-controlling interest | |||||
| Net loss attributable to Stem Holdings | |||||
| Net loss per share, basic and diluted | |||||
| Weighted-average shares outstanding, basic and diluted | |||||
| Net income (loss) per share: | |||||
| Basic net income (loss) from continuing operations, per share | |||||
| Diluted net income (loss) from continuing operations, per share | |||||
| Basic net income (loss) from discontinued operations, per share | |||||
| Diluted net income (loss) from discontinued operations, per share | |||||
| Basic net income (loss), per share | |||||
| Diluted net income (loss), per share | |||||
| Weighted-average shares outstanding | |||||
| Basic | |||||
| Diluted | |||||
Loading...